PrimeVigilance is pleased to announce that both Dr. Michael Forstner (PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology) and Dr Jan Petracek (PrimeVigilance CEO, and former Head of Risk Management at EMA) were selected expert speakers during the upcoming DIA Pharmacovigilance and Risk Management Strategies Conference held this January 28-30, 2019 in Washington, DC.
Published
13 December 2018.
London, UK – 28 November 2018: Ergomed plc (LSE: ERGO) (‘Ergomed’ or ‘the Company’), a company focused on providing specialised services to the pharmaceutical industry, is delighted to have been shortlisted for the Best Technological Development in Clinical Trials category at the 14th Annual SCRIP Awards
Published
28 November 2018.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)
USA
Croatia
Serbia
Czech Republic
Germany
© PrimeVigilance 2018 An 
group company
© PrimeVigilance 2018